Table 1.
Baseline demographics and clinical characteristics of the study population.
| Characteristic | Value |
|---|---|
| Number of successfully implanted patients | 24 |
| Age (years) | |
| Mean (SD) | 77.0 (6.2) |
| Range | 69–91 years |
| Gender | |
| Female | 13 (54.2%) |
| Male | 11 (45.8%) |
| Study eye | |
| Right | 16 (66.7%) |
| Left | 8 (33.3%) |
| Race | |
| Caucasian | 24 (100.0%) |
| Mean CDVA (ETDRS letters) ± SD | |
| Study eye | 8.5 ± 7.3 |
| Fellow eye | 7.4 ± 7.2 |
| Mean CDNVA (Jaeger levels) ± SD | |
| Study eye | 15.6 ± 3.9 |
| Fellow eye | 15.2 ± 2.8 |
| Mean ECD (cells/mm2) ± SD | |
| Study eye | 2431.0 ± 318.5 |
| Fellow eye | 2309.6 ± 452.6 |
| Mean IOP (mmHg) ± SD | |
| Study eye | 14.1 ± 2.8 |
| Fellow eye | 14.3 ± 2.4 |
| Mean ACD (mm) ± SD | |
| Study eye | 3.272 ± 0.806 |
| Fellow eye | 3.498 ± 0.958 |
| Macular lesion (study eye) | |
| Disciform scar associated with CNV | 5 (20.8%) |
| Geographic atrophy | 19 (79.2%) |
SD = standard deviation; CDVA = best-corrected distance visual acuity; CDNVA = best-corrected near visual acuity; ECD = endothelial cell density; IOP = intraocular pressure; ACD = anterior chamber depth; CNV = choroidal neovascularization. Unless otherwise indicated, data are expressed as number (percentage) of participants.